ScholarLens Back to search
2012•Pediatric Hematology and OncologyRequires access

Sustained Molecular Remission after Arsenic Trioxide and Gemutuzumab Ozogamicin in a Pediatric Patient with Relapsed Acute Promyelocytic Leukemia

Akiko Inoue, Chihiro Kawakami, Kimitaka Takitani, Hiroshi Tamai

Open publisher page 3 citations

Abstract

Acute promyelocytic leukemia (APL) is characterized by a specific chromosomal translocation, t(15;17)(q22;q21), which leads to a promyelocytic leukemia (PML) - retinoic acid receptor α (RARα) fusio...

About this research paper

What this paper is about

Acute promyelocytic leukemia (APL) is characterized by a specific chromosomal translocation, t(15;17)(q22;q21), which leads to a promyelocytic leukemia (PML) - retinoic acid receptor α (RARα) fusio...

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Acute promyelocytic leukemia (APL) is characterized by a specific chromosomal translocation, t(15;17)(q22;q21), which leads to a promyelocytic leukemia (PML) - retinoic acid receptor α (RARα) fusio...

Key concepts: Arsenic trioxide, Acute promyelocytic leukemia, Medicine, Promyelocytic leukemia protein, Leukemia, Chromosomal translocation, Cancer research, Retinoic acid

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Sustained Molecular Remission after Arsenic Trioxide and Gemutuzumab Ozogamicin in a Pediatric Patient with Relapsed Acute Promyelocytic Leukemia — Research Paper | ScholarLens